Navigation Links
NYC's First Rapid HIV Drug-resistant AIDS Case Prompts Call to Step Up HIV Prevention

New York City's Public Health Department today issued a public health advisory after reporting the first documented case of an alarming, new, rapidly-progressing and highly drug resistant strain of HIV in a New York man who progressed from his initial HIV infection, thought to have occurred in mid-October 2004, to a largely untreatable strain of AIDS in just three months.

According to City health officials, the man -- who had previously had five negative HIV tests done by his private physician between September 2000 and May 2003 -- had unprotected sex with numerous male partners in mid-October, reported feeling unwell in late October and November, and subsequently had positive ELISA and Western Blot (HIV tests) documented in mid-December. The individual then progressed to a diagnosis of highly drug-resistant AIDS by mid-January. Ordinarily, it has taken up to ten years for an untreated individual to progress from HIV infection to an AIDS defining illness and diagnosis.

"It appears this individual has contracted a new, particularly virulent strain of HIV that swiftly advanced to AIDS in just a few short months," said Charles Farthing, MD, AIDS Healthcare Foundation's Chief of Medicine. "Unfortunately, it also seems that few of the AIDS treatments currently available today can be used in his case, as his particular strain of infection appears to be resistant to most known AIDS drugs. AIDS care providers see many cases of patients with a high degree of some drug resistance; however, doctors and providers can usually find a second or third line drug therapy regimen for effective treatment. This man's strain of infection appears to be much more pathogenic, much more able to wreak havoc with his immune system, and medical providers and public health officials are being well-advised to work closely together to monitor -- and hopefully prevent transmission of -- this strain of the virus by encouraging gay men, in particular, to practice safer sex and use cond oms during all sexual encounters."

"This case in New York underscores the crucial need to step up collaborative efforts among public health officials, medical providers and AIDS groups to fine tune and develop aggressive, ongoing and innovative HIV prevention programs with a particular emphasis on targeting high-risk populations," said Michael Weinstein, AIDS Healthcare Foundation President. "Clearly men who have sex with men continue to be at risk, as well as African Americans, as President Bush noted last week in his State of the Union address. Rather than demonizing particular individuals or groups, we need to work together develop a more pragmatic and comprehensive public health approach to fighting HIV, including addressing many of the underlying reasons people put themselves at risk-including undiagnosed depression and poor access to mental health services -- if we are to truly break the chain of infection through effective prevention, testing and treatment efforts."


'"/>

Source:AIDS Healthcare Foundation


Related biology news :

1. Timing is everything: First step in protein building revealed
2. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
3. First atlas of key brain genes could speed research on cancer, neurological diseases
4. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
5. First real-time view of developing neurons reveals surprises, say Stanford researchers
6. Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth
7. Mayo Clinic Researchers Create Obedient Virus; First Step To Use Measles Virus Against Cancer
8. First frozen egg baby born in Canada
9. Human Cells Filmed Instantly Messaging for First Time
10. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
11. First technology to remove prions that cause vCJD from blood launched
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)... NEW YORK , April 5, 2017 ... security, is announcing that the server component of the ... is known for providing the end-to-end security architecture that ... customers. HYPR has already secured over 15 ... system makers including manufacturers of connected home product suites ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... 2017  VMS BioMarketing, a leading provider of patient support ... Nurse Educator (CNE) network, which will launch this week. The ... health care professionals to enhance the patient care experience by ... other health care professionals to help women who have been ... ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
Breaking Biology Technology: